John Wiley & Sons earnings release, June 16, 2026
Research and AI Momentum, Record Margins, and Cash Flow Growth Highlight Wiley's Fourth Quarter and Fiscal 2026 Results
June 16, 2026 - Hoboken, NJ – Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the fourth quarter and fiscal year ended April 30, 2026.
Fiscal 2026 Highlights
• GAAP performance vs. prior year:
Revenue of $1,677 is flat including impact of divestitures; Operating Income of $277 million vs. $221 million (+25%); and Diluted Earnings Per Share (EPS) of $4.16 vs. $1.53
• Adjusted Results at constant currency
:
Adjusted Revenue of $1,677 million vs. $1,660 million (+1% or flat at constant currency) with Research growth offset by market-related softness in Learning; Adjusted Operating Income of $296 million up 18% with margin expanding by 260 basis points to a record 17.7%; Adjusted EBITDA of $440 million up 10% with margin expanding by 220 basis points to 26.2%; Adjusted EPS rose 15% to $4.19
• Research momentum:
Delivered 5% revenue growth or 4% at constant currency and over 100 basis points of Adjusted EBITDA margin improvement; after fiscal year-end, acquired Emerald Publishing to increase scale in Research and proprietary content advantage in AI economy, and appointed new leader in Research
• AI and data analytics momentum:
Delivered $49 million of AI revenue (+23%) with recurring revenue rapidly scaling; appointed Chief AI and Data Analytics Officer; early lead in life sciences and healthcare AI with landmark partnerships and corporate customer signings; lifetime AI revenue surpassed $110 million
• Continued cash flow growth:
Operating Cash Flow of $261 million (+29%) and Free Cash Flow of $195 million (+55%) driven by higher cash earnings and lower capex moderated by late renewal signings impacting the timing of cash collection
• Record return to shareholders:
Returned record $174 million to shareholders through dividends and share repurchases, including $100 million of repurchases, and raised dividend for 32nd consecutive year
Management Commentary
“Fiscal 2026 was Wiley’s breakout year,” said Matthew Kissner, President and CEO.
“We accelerated our two reinforcing growth engines — Research and AI and data analytics – while delivering record margins and a significant step change in Free Cash Flow.
Research delivered mid-single digit growth on record submissions and output, and the recent acquisition of Emerald Publishing further extends our scale and proprietary content advantage in the AI economy.
AI revenue grew double digits to nearly $50 million with a rapidly expanding recurring stream, anchored by landmark partnerships with IQVIA and OpenEvidence and a growing roster of corporate customers.
With momentum across both growth engines and a proven playbook, we enter Fiscal 2027 with our strongest conviction yet.”
Q4 Financial Summary
Please see accompanying financial tables for more detail on fourth quarter and full year results.
• Q4 reported revenue of $448 million (+1% as reported, flat at constant currency, or CC)
• Q4 Diluted EPS of $2.61 (+109%); Adjusted EPS +22% (CC) to $1.67 and Adjusted EBITDA +17% (CC) to $149 million with margin up 480 basis points to 33.2%.
Research Segment
• Q4 Research revenue of $296 million was up 5% as reported and 4% (CC), with Research Publishing up 5% (CC) largely driven by strong growth in gold open access and AI licensing.
This was partially offset by a 4% decline (CC) in Research Solutions due to a soft recruitment market. Q4 Adjusted EBITDA of $111 million was up 13% (CC). Adjusted EBITDA margin for the quarter rose 300 basis points to 37.7%.
• Full year Research revenue of $1,130 million was up 5% as reported and 4% CC, driven by growth in recurring revenue models (subscriptions and transformational agreements), gold open access, and AI licensing.
Growth trends remained favorable, with submissions and output up significantly.
Full year Adjusted EBITDA of $375 million was up 8% (CC).
Adjusted EBITDA margin for the year rose 110 basis points to 33.2%.
Learning Segment
• Q4 Learning revenue of $152 million was down 6% as reported and 7% (CC) reflecting lower AI licensing revenue in Academic and Professional, macro headwinds, and retail channel softness. Q4 Adjusted EBITDA of $70 million was down 1% (CC). Adjusted EBITDA margin was up 310 basis points to 46.1%, driven by cost discipline and favorable mix.
• Full year Learning revenue of $547 million was down 7% as reported and at constant currency due to macro headwinds, retail channel softness, and lower AI licensing revenue.
Learning Adjusted EBITDA of $208 million for the year was down 6% (CC). Adjusted EBITDA margin rose 60 basis points to 38.0% on continued cost actions.
Corporate Expenses
“Corporate Expenses” are the portion of shared services costs not allocated to segments.
• Q4 Corporate Expenses on an Adjusted EBITDA basis declined 21% as reported and 22% at constant currency on technology transformation and continued restructuring savings, contributing to Adjusted EBITDA margin expansion in the quarter.
• Full year Corporate Expenses on an Adjusted EBITDA basis declined 14% on a reported basis and 15% at constant currency.
Balance Sheet, Cash Flow, and Capital Allocation
• Net Debt-to-EBITDA ratio improved to 1.4x compared to 1.8x in the year-ago period, reflecting higher Adjusted EBITDA and lower net debt of $608 million vs. $714 million due to settlement from a prior divestiture.
• Net Cash provided by Operating Activities was $261 million (+29%), driven by higher Adjusted EBITDA, lower restructuring payments, and reduced retirement obligations.
• Free Cash Flow was up 55% to $195 million primarily driven by higher operating cash flow and lower capex.
Note that Free Cash Flow was moderated by late renewal signings impacting the timing of cash collection.... (truncated) vs. $77 million in the prior year.
• Returns to Shareholders: Wiley allocated $174 million toward dividends and share repurchases, up from $137 million in the prior year. $100 million was allocated to share repurchases, up from $60 million in the prior-year period, and the dividend was raised for the 32nd consecutive year.
New Business Leaders
Wiley strengthened its leadership team this year to accelerate its AI and Research strategy. In January 2026, Armughan Rafat joined as Chief AI and Data Analytics Officer, a newly created role on the Executive Leadership Team, to lead the commercialization of AI-ready content and data products for AI developers and corporate R&D teams. Rafat previously served as Chief Analytics Officer at Norstella and Chief Data Officer at Clarivate.
In May 2026, Jessica Kowalski joined Wiley as Executive Vice President and General Manager, Research, succeeding Jay Flynn. Kowalski joins from Microsoft and brings more than two decades of experience across research publishing and AI-enabled businesses, including prior senior roles at Amazon Web Services and RELX.
Fiscal 2027 Outlook
*Organic Revenue Growth” excludes the effects of the Emerald acquisition and currency movements.
All other metrics include the addition of Emerald.
Emerald is projected to add $78 million to Revenue (11 months of Fiscal Year) and be accretive to Adjusted EPS by approximately $0.10 and dilutive to Free Cash Flow by $15 million (the Emerald acquisition is expected to turn Free Cash Flow accretive in Fiscal 2028)
• Organic Revenue Growth
- driven by expected core growth in Research, improvement in Learning, and another strong year in AI and data analytics
• Adjusted EBITDA Margin – reflecting anticipated cost savings and ongoing efficiency gains balanced with high-return, sustainable growth investment
• Adjusted EPS – growth expectation driven by higher expected Adjusted Operating Income
• Free Cash Flow – driven by expected cash earnings growth partially offset by year 1 dilution from Emerald ($15M), higher capex ($80M vs. $65M in FY26), expected restructuring costs, and higher cash taxes
Earnings Conference Call
Scheduled for today, June 16 at 10:00 am (ET).
Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/978555203. North American callers, please dial (833) 461-5787 and enter the meeting ID: 373431738. International callers, please dial (585) 542-9983 and enter the meeting ID:
373431738.
About Wiley
Wiley (NYSE: WLY) is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram
Non-GAAP Financial Measures
Wiley provides non-GAAP financial measures and performance results such as “Adjusted EPS,” “Adjusted Operating Income,” “Adjusted EBITDA,” “Adjusted Income before Taxes,” “Adjusted Income Tax Provision,” “Adjusted Effective Income Tax Rate,” “Free Cash Flow less Product Development Spending,” “organic revenue,” “Adjusted Revenue,” and results on a Constant Currency basis to assess underlying business performance and trends.
Management believes non-GAAP financial measures, which exclude the impact of restructuring charges and credits and certain other items, and the impact of divestitures and acquisitions provide a useful comparable basis to analyze operating results and earnings.
See the reconciliations of non-GAAP financial measures and explanations of the uses of non-GAAP measures in the supplementary information.
We have not provided our 2027 outlook for the most directly comparable U.S. GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain items, including restructuring charges and credits, gains and losses on foreign currency, and other gains and losses.
These items are uncertain, depend on various factors, and could be material to our consolidated results computed in accordance with U.S. GAAP.
Financial statements
Income Statement
Three Months Ended April 30, — (unaudited)
| Three Months Ended April 30, – 2026 | Three Months Ended April 30, – 2025 | Year Ended April 30, – 2026 | Year Ended April 30, – 2025 | ||
|---|---|---|---|---|---|
| Revenue, net | 447,941 | 442,579 | 1,676,528 | 1,677,609 | |
| Costs and expenses: | Cost of sales | 110,081 | 110,941 | 431,509 | 431,380 |
| Costs and expenses: | Operating and administrative expenses | 211,393 | 229,767 | 895,907 | 947,437 |
| Costs and expenses: | Restructuring and related charges | 3,076 | 12,490 | 19,203 | 25,561 |
| Costs and expenses: | Amortization of intangible assets | 13,249 | 12,909 | 53,050 | 51,822 |
| Costs and expenses: | Total costs and expenses | 337,799 | 366,107 | 1,399,669 | 1,456,200 |
| Costs and expenses: | Operating income | 110,142 | 76,472 | 276,859 | 221,409 |
| Costs and expenses: | As a % of revenue | 24.6 | 17.3 | 16.5 | 13.2 |
| Costs and expenses: | Interest expense | -9,646 | -11,270 | -43,848 | -52,547 |
| Costs and expenses: | Net foreign exchange transaction losses | -1,362 | -826 | -6,564 | -8,142 |
| Costs and expenses: | Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | -1,242 | -13,580 | -4,828 | -23,340 |
| Costs and expenses: | Other (expense) income, net | -2,919 | 1,469 | -6,533 | 5,498 |
| Costs and expenses: | Income before taxes | 94,973 | 52,265 | 215,086 | 142,878 |
| Costs and expenses: | (Benefit) provision for income taxes | -40,374 | -15,828 | -6,531 | 58,717 |
| Costs and expenses: | Effective tax rate | -42.5 | -30.3 | -3 | 41.1 |
| Costs and expenses: | Net income | 135,347 | 68,093 | 221,617 | 84,161 |
| Costs and expenses: | As a % of revenue | 30.2 | 15.4 | 13.2 | 5 |
| Earnings per share | Basic | 2.65 | 1.27 | 4.22 | 1.56 |
| Earnings per share | Diluted | 2.61 | 1.25 | 4.16 | 1.53 |
| Weighted average number of common shares outstanding | Basic | 51,109 | 53,683 | 52,466 | 54,054 |
| Weighted average number of common shares outstanding | Diluted | 51,914 | 54,458 | 53,247 | 54,830 |
Income Statement
(unaudited)
| Reconciliation of US GAAP Earnings per Share to Non-GAAP Adjusted EPS – Three Months Ended April 30, – 2026 | Three Months Ended April 30, – 2026 | Reconciliation of US GAAP Earnings per Share to Non-GAAP Adjusted EPS – Three Months Ended April 30, – 2025 | Three Months Ended April 30, – 2025 | Reconciliation of US GAAP Earnings per Share to Non-GAAP Adjusted EPS – Year Ended April 30, – 2026 | Year Ended April 30, – 2026 | Reconciliation of US GAAP Earnings per Share to Non-GAAP Adjusted EPS – Year Ended April 30, – 2025 | Year Ended April 30, – 2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| US GAAP Earnings Per Share - Diluted | 2.61 | 1.25 | 4.16 | 1.53 | |||||
| Adjustments: | Restructuring and related charges | 0.03 | 0.14 | 0.27 | 0.36 | ||||
| Adjustments: | Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 0.02 | -0.01 | 0.05 | 0.08 | ||||
| Adjustments: | Amortization of acquired intangible assets | 0.15 | 0.15 | 0.79 | 0.76 | ||||
| Adjustments: | Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | -0.01 | 0.18 | 0.08 | 0.38 | ||||
| Adjustments: | Held for Sale or Sold segment Adjusted Net Loss | 0.05 | |||||||
| Adjustments: | Income tax adjustments | -1.13 | -0.34 | -1.16 | 0.48 | ||||
| Adjustments: | Non-GAAP Adjusted Earnings Per Share - Diluted | 1.67 | 1.37 | 4.19 | 3.64 | ||||
| Reconciliation of US GAAP Income Before Taxes to Non-GAAP Adjusted Income Before Taxes | US GAAP Income Before Taxes | 94,973 | 52,265 | 215,086 | 142,878 | ||||
| Pretax Impact of Adjustments: | Restructuring and related charges | 3,076 | 12,490 | 19,203 | 25,561 | ||||
| Pretax Impact of Adjustments: | Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 1,001 | 2,881 | 5,590 | |||||
| Pretax Impact of Adjustments: | Amortization of acquired intangible assets | 13,249 | 12,908 | 53,050 | 51,864 | ||||
| Pretax Impact of Adjustments: | Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | 1,242 | 13,580 | 4,828 | 23,340 | ||||
| Pretax Impact of Adjustments: | Held for Sale or Sold segment Adjusted Loss Before Taxes | 3,578 | |||||||
| Pretax Impact of Adjustments: | Legal settlement | 108 | |||||||
| Pretax Impact of Adjustments: | Non-GAAP Adjusted Income Before Taxes | 113,541 | 91,243 | 295,156 | 252,811 | ||||
| Reconciliation of US GAAP Income Tax (Benefit) Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate | US GAAP Income Tax (Benefit) Provision | -40,374 | -15,828 | -6,531 | 58,717 | ||||
| Income Tax Impact of Adjustments(3) | Restructuring and related charges | 1,444 | 4,633 | 4,682 | 5,947 | ||||
| Income Tax Impact of Adjustments(3) | Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 118 | 571 | 464 | 1,170 | ||||
| Income Tax Impact of Adjustments(3) | Amortization of acquired intangible assets | 5,313 | 4,720 | 11,298 | 10,231 | ||||
| Income Tax Impact of Adjustments(3) | Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | 1,684 | 3,715 | 480 | 2,368 | ||||
| Income Tax Impact of Adjustments(3) | Held for Sale or Sold segment Adjusted Tax Benefit | 807 | |||||||
| Income Tax Adjustments | Impact of withholding tax on Sri Lanka distribution | 226 | -982 | ||||||
| Income Tax Adjustments | Impact of valuation allowance on the US GAAP effective tax rate | 57,990 | 18,776 | 58,324 | -26,008 | ||||
| Income Tax Adjustments | Impact of change in Germany statutory tax rate on deferred tax balances | 418 | 4,286 |
Income Statement
Three Months Ended April 30, — (unaudited)
| Three Months Ended April 30, – 2026 | Three Months Ended April 30, – 2025 | Year Ended April 30, – 2026 | Year Ended April 30, – 2025 | |
|---|---|---|---|---|
| Net Income | 135,347 | 68,093 | 221,617 | 84,161 |
| Interest expense | 9,646 | 11,270 | 43,848 | 52,547 |
| (Benefit) provision for income taxes | -40,374 | -15,828 | -6,531 | 58,717 |
| Depreciation and amortization | 35,510 | 36,681 | 143,477 | 147,126 |
| Non-GAAP EBITDA | 140,129 | 100,216 | 402,411 | 342,551 |
| Restructuring and related charges | 3,076 | 12,490 | 19,203 | 25,561 |
| Net foreign exchange transaction losses | 1,362 | 826 | 6,564 | 8,142 |
| Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | 1,242 | 13,580 | 4,828 | 23,340 |
| Other expense (income), net | 2,919 | -1,469 | 6,533 | -5,498 |
| Held for Sale or Sold segment Adjusted EBITDA | 3,578 | |||
| Legal settlement | 108 | |||
| Non-GAAP Adjusted EBITDA | 148,728 | 125,643 | 439,647 | 397,674 |
| Adjusted EBITDA Margin | 33.2 | 28.4 | 26.2 | 24 |
Income Statement
(unaudited)
| Three Months Ended April 30, – 2026 | Three Months Ended April 30, – 2025 | % Change – Favorable (Unfavorable) – Reported | % Change – Favorable (Unfavorable) – Constant Currency | ||
|---|---|---|---|---|---|
| Revenue, net | Research Publishing | 259,123 | 243,061 | 7.0% | 5.0% |
| Revenue, net | Research Solutions | 36,494 | 37,660 | -3.0% | -4.0% |
| Revenue, net | Total Revenue, net | 295,617 | 280,721 | 5.0% | 4.0% |
| Revenue, net | Non-GAAP Adjusted Operating Income | 88,664 | 75,168 | 18.0% | 17.0% |
| Revenue, net | Depreciation and amortization | 22,744 | 22,303 | -2.0% | 0.0% |
| Revenue, net | Non-GAAP Adjusted EBITDA | 111,408 | 97,471 | 14.0% | 13.0% |
| Revenue, net | Adjusted EBITDA margin | 37.7% | 34.7% | ||
| Revenue, net | Academic | 96,147 | 100,146 | -4.0% | -5.0% |
| Revenue, net | Professional | 56,177 | 61,712 | -9.0% | -10.0% |
| Revenue, net | Total Revenue, net | 152,324 | 161,858 | -6.0% | -7.0% |
| Revenue, net | Non-GAAP Adjusted Operating Income | 59,705 | 58,715 | 2.0% | 0.0% |
| Revenue, net | Depreciation and amortization | 10,445 | 10,948 | 5.0% | 6.0% |
| Revenue, net | Non-GAAP Adjusted EBITDA | 70,150 | 69,663 | 1.0% | -1.0% |
| Revenue, net | Adjusted EBITDA margin | 46.1% | 43.0% | ||
| Corporate Expenses: | Non-GAAP Adjusted Corporate Expenses | -35,151 | -44,921 | 22.0% | 23.0% |
| Corporate Expenses: | Depreciation and amortization | 2,321 | 3,430 | 32.0% | 33.0% |
| Corporate Expenses: | Non-GAAP Adjusted EBITDA | -32,830 | -41,491 | 21.0% | 22.0% |
| Consolidated Results: | Revenue, net | 447,941 | 442,579 | 1.0% | 0.0% |
| Consolidated Results: | Operating Income | 110,142 | 76,472 | 44.0% | 43.0% |
| Adjustments: | Restructuring charges | 3,076 | 12,490 | 75.0% | 75.0% |
| Adjustments: | Non-GAAP Adjusted Operating Income | 113,218 | 88,962 | 27.0% | 26.0% |
| Adjustments: | Adjusted Operating Income margin | 25.3% | 20.1% | ||
| Adjustments: | Depreciation and amortization | 35,510 | 36,681 | 3.0% | 5.0% |
| Adjustments: | Non-GAAP Adjusted EBITDA | 148,728 | 125,643 | 18.0% | 17.0% |
| Adjustments: | Adjusted EBITDA margin | 33.2% | 28.4% |
Income Statement
(unaudited)
| Year Ended April 30, – 2026 | Year Ended April 30, – 2025 | % Change – Favorable (Unfavorable) – Reported | % Change – Favorable (Unfavorable) – Constant Currency | ||
|---|---|---|---|---|---|
| Revenue, net | Research Publishing | 965,767 | 922,553 | 5.0% | 3.0% |
| Revenue, net | Research Solutions | 164,175 | 152,906 | 7.0% | 6.0% |
| Revenue, net | Total Revenue, net | 1,129,942 | 1,075,459 | 5.0% | 4.0% |
| Revenue, net | Non-GAAP Adjusted Operating Income | 282,604 | 255,580 | 11.0% | 10.0% |
| Revenue, net | Depreciation and amortization | 92,472 | 89,302 | -4.0% | -2.0% |
| Revenue, net | Non-GAAP Adjusted EBITDA | 375,076 | 344,882 | 9.0% | 8.0% |
| Revenue, net | Adjusted EBITDA margin | 33.2% | 32.1% | ||
| Revenue, net | Academic | 318,757 | 333,693 | -4.0% | -5.0% |
| Revenue, net | Professional | 227,829 | 251,075 | -9.0% | -10.0% |
| Revenue, net | Total Revenue, net | 546,586 | 584,768 | -7.0% | -7.0% |
| Revenue, net | Non-GAAP Adjusted Operating Income | 166,385 | 174,850 | -5.0% | -5.0% |
| Revenue, net | Depreciation and amortization | 41,148 | 43,900 | 6.0% | 7.0% |
| Revenue, net | Non-GAAP Adjusted EBITDA | 207,533 | 218,750 | -5.0% | -6.0% |
| Revenue, net | Adjusted EBITDA margin | 38.0% | 37.4% | ||
| Held for Sale or Sold: | Total Revenue, net | $— | 17,382 | # | # |
| Held for Sale or Sold: | Non-GAAP Adjusted Operating Loss | $— | -3,578 | # | # |
| Held for Sale or Sold: | Depreciation and amortization | # | # | ||
| Held for Sale or Sold: | Non-GAAP Adjusted EBITDA | $— | -3,578 | # | # |
| Held for Sale or Sold: | Adjusted EBITDA margin | 0.0% | -20.6% | ||
| Corporate Expenses: | Non-GAAP Adjusted Corporate Expenses | -152,819 | -179,882 | 15.0% | 16.0% |
| Corporate Expenses: | Depreciation and amortization | 9,857 | 13,924 | 29.0% | 30.0% |
| Corporate Expenses: | Non-GAAP Adjusted EBITDA | -142,962 | -165,958 | 14.0% | 15.0% |
| Consolidated Results: | Revenue, net | 1,676,528 | 1,677,609 | 0.0% | -1.0% |
| Consolidated Results: | Less: Held for Sale or Sold Segment | -17,382 | # | # | |
| Consolidated Results: | Adjusted Revenue, net | 1,676,528 | 1,660,227 | 1.0% | 0.0% |
| Consolidated Results: | Operating Income | 276,859 | 221,409 | 25.0% | 25.0% |
| Adjustments: | Restructuring charges | 19,203 | 25,561 | 25.0% | 25.0% |
| Adjustments: | Held for Sale or Sold Segment Adjusted Operating Loss | 3,578 | # | # | |
| Adjustments: | Legal settlement | 108 | # | # | |
| Adjustments: | Non-GAAP Adjusted Operating Income | 296,170 | 250,548 | 18.0% | 18.0% |
| Adjustments: | Adjusted Operating Income margin | 17.7% | 15.1% |
Balance Sheet
(unaudited)
| April 30, 2026 | April 30, 2025 | ||
|---|---|---|---|
| Current assets | Cash and cash equivalents | 75,622 | 85,882 |
| Current assets | Accounts receivable, net | 244,164 | 228,410 |
| Current assets | Inventories, net | 19,265 | 22,875 |
| Current assets | Prepaid expenses and other current assets | 80,614 | 102,717 |
| Current assets | Total current assets | 419,665 | 439,884 |
| Current assets | Technology, property and equipment, net | 136,260 | 162,125 |
| Current assets | Intangible assets, net | 578,959 | 595,044 |
| Current assets | Goodwill | 1,132,392 | 1,121,505 |
| Current assets | Operating lease right-of-use assets | 57,128 | 66,128 |
| Current assets | Other non-current assets | 267,414 | 306,780 |
| Current assets | Total assets | 2,591,818 | 2,691,466 |
| Current liabilities | Accounts payable | 67,199 | 60,948 |
| Current liabilities | Accrued royalties | 97,791 | 109,765 |
| Current liabilities | Short-term portion of long-term debt | 12,500 | 10,000 |
| Current liabilities | Contract liabilities | 451,423 | 462,693 |
| Current liabilities | Accrued employment costs | 71,068 | 93,117 |
| Current liabilities | Short-term portion of operating lease liabilities | 15,954 | 18,282 |
| Current liabilities | Other accrued liabilities | 63,012 | 66,051 |
| Current liabilities | Total current liabilities | 778,947 | 820,856 |
| Current liabilities | Long-term debt | 670,897 | 789,435 |
| Current liabilities | Accrued pension liability | 59,527 | 71,899 |
| Current liabilities | Deferred income tax liabilities | 98,972 | 105,145 |
| Current liabilities | Operating lease liabilities | 69,544 | 81,482 |
| Current liabilities | Other long-term liabilities | 65,689 | 70,443 |
| Current liabilities | Total liabilities | 1,743,576 | 1,939,260 |
| Current liabilities | Shareholders' equity | 848,242 | 752,206 |
| Current liabilities | Total liabilities and shareholders' equity | 2,591,818 | 2,691,466 |
Cash Flow
Year Ended April 30, — (unaudited)
| Year Ended April 30, – 2026 | Year Ended April 30, – 2025 | ||
|---|---|---|---|
| Operating activities: | Net income | 221,617 | 84,161 |
| Operating activities: | Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | 4,828 | 23,340 |
| Operating activities: | Amortization of intangible assets | 53,050 | 51,822 |
| Operating activities: | Amortization of product development assets | 16,058 | 16,610 |
| Operating activities: | Amortization of cloud computing arrangements | 2,770 | 1,081 |
| Operating activities: | Depreciation and amortization of technology, property, and equipment | 74,369 | 78,694 |
| Operating activities: | Other noncash charges | 23,735 | 101,808 |
| Operating activities: | Net change in operating assets and liabilities | -135,908 | -154,925 |
| Operating activities: | Net cash provided by operating activities | 260,519 | 202,591 |
| Investing activities: | Additions to technology, property, and equipment | -51,166 | -61,473 |
| Investing activities: | Product development spending | -14,012 | -15,228 |
| Investing activities: | Businesses acquired in purchase transactions, net of cash acquired | -243 | -3,602 |
| Investing activities: | Net cash proceeds (transferred) related to the sale of businesses and assets | 112,194 | -7,642 |
| Investing activities: | Acquisitions of publication rights and other | -18,668 | -6,073 |
| Investing activities: | Net cash provided by (used in) investing activities | 28,105 | -94,018 |
| Financing activities: | Net debt (repayments) borrowings | -120,297 | 13,509 |
| Financing activities: | Cash dividends | -74,358 | -76,101 |
| Financing activities: | Purchases of treasury shares | -100,082 | -60,421 |
| Financing activities: | Other | -3,566 | -2,317 |
| Financing activities: | Net cash used in financing activities | -298,303 | -125,330 |
| Financing activities: | Effects of exchange rate changes on cash, cash equivalents and restricted cash | -581 | 3,146 |
| Financing activities: | Change in cash, cash equivalents and restricted cash for period | -10,260 | -13,611 |
| Financing activities: | Cash, cash equivalents and restricted cash - beginning | 85,932 | 99,543 |
| Financing activities: | Cash, cash equivalents and restricted cash - ending | 75,672 | 85,932 |
| Financing activities: | CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING (3) | CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING (3) | |
| Financing activities: | Net cash provided by operating activities | 260,519 | 202,591 |
| Financing activities: | Less: Additions to technology, property, and equipment | -51,166 | -61,473 |
| Financing activities: | Less: Product development spending | -14,012 | -15,228 |
| Financing activities: | Free cash flow less product development spending | 195,341 | 125,890 |
Full release
Forward-Looking Statements
This release contains certain forward-looking statements concerning the Company's operations, performance, and financial condition.
Reliance should not be placed on forward-looking statements, as actual results may differ materially from those in any forward-looking statements.
Any such forward-looking statements are based upon a number of assumptions and estimates that are inherently subject to uncertainties and contingencies, many of which are beyond the control of the Company and are subject to change based on many important factors.... (truncated)ection with our multiyear Global Restructuring Program and completed dispositions; (xi) cyber risk and the failure to maintain the integrity of our operational or security systems or infrastructure, or those of third parties with which we do business; (xii) as a result of acquisitions, we have and may record a significant amount of goodwill and other identifiable intangible assets and we may never realize the full carrying value of these assets; and (xiii) other factors detailed from time to time in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise forward-looking statements to reflect subsequent events.
Category: Corporate News/ Earnings Releases
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION
(1) (2)
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME
(in USD thousands, except per share information)
(unaudited)
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION
(1) (2)
RECONCILIATION OF US GAAP MEASURES to NON-GAAP MEASURES
(in USD thousands, except per share information)
(unaudited)
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION
(1) (2)
RECONCILIATION OF US GAAP NET INCOME TO NON-GAAP EBITDA AND ADJUSTED EBITDA
(in USD thousands)
(unaudited)
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION
(1) (2) (3)
SEGMENT RESULTS
(in USD thousands)
(unaudited)
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION
(1) (2) (3)
SEGMENT RESULTS
(in USD thousands)
(unaudited)
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION